Patents by Inventor Jer-Cheng KUO

Jer-Cheng KUO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRODUCTION OF RECOMBINANT HUMAN A-THROMBIN IN PLANT-BASED SYSTEM AND THE APPLICATION THEREOF
    Publication number: 20240132904
    Abstract: The present invention relates to a method for producing recombinant human prethrombin-2 protein and having human ?-thrombin activity by the plant-based expression systems.
    Type: Application
    Filed: October 16, 2023
    Publication date: April 25, 2024
    Applicant: PROVIEW-MBD BIOTECH CO., LTD.
    Inventors: Yu-Chia CHANG, Jer-Cheng KUO, Ruey-Chih SU, Li-Kun HUANG, Ya-Yun LIAO, Ching-I LEE, Shao-Kang HUNG
  • Acellular organs, and methods of producing the same
    Patent number: 11951233
    Abstract: Provided are methods of producing an acellular organ. The method includes the steps of, subjecting an organ derived from an animal to a static supercritical fluid (SCF) treatment followed by a dynamic SCF treatment. Optionally, the method of the present disclosure further includes a hypertonic and a hypotonic treatments prior to the static SCF treatment, and/or a neutralizing treatment after the dynamic SCF treatment. Also disclosed herein are acellular organs produced by the present method.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: April 9, 2024
    Assignee: ACRO BIOMEDICAL COMPANY. LTD.
    Inventors: Dar-Jen Hsieh, Chao-Yi Wei, Chao-Chin Chao, Jer-Cheng Kuo, Yi-Ping Lai, Srinivasan Periasamy
  • ACELLULAR ORGANS, AND METHODS OF PRODUCING THE SAME
    Publication number: 20210205497
    Abstract: Provided are methods of producing an acellular organ. The method includes the steps of, subjecting an organ derived from an animal to a static supercritical fluid (SCF) treatment followed by a dynamic SCF treatment. Optionally, the method of the present disclosure further includes a hypertonic and a hypotonic treatments prior to the static SCF treatment, and/or a neutralizing treatment after the dynamic SCF treatment. Also disclosed herein are acellular organs produced by the present method.
    Type: Application
    Filed: September 11, 2019
    Publication date: July 8, 2021
    Applicant: ACRO BIOMEDICAL COMPANY. LTD.
    Inventors: Dar-Jen HSIEH, Chao-Yi WEI, Chao-Chin CHAO, Jer-Cheng KUO, Yi-Ping LAI, Srinivasan PERIASAMY